Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19

Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019., N Engl J Med, 382, 727, 10.1056/NEJMoa2001017

Richardson, 2020, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area., JAMA, 323, 2052, 10.1001/jama.2020.6775

Docherty, Features of 20?133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study., BMJ

Grasselli, 2020, Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy., JAMA, 323, 1574, 10.1001/jama.2020.5394

Ackermann, 2020, Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19., N Engl J Med, 383, 120, 10.1056/NEJMoa2015432

Moore, 2020, Cytokine release syndrome in severe COVID-19., Science, 368, 473, 10.1126/science.abb8925

Qin, 2020, Dysregulation of Immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China., Clin Infect Dis, 71, 762, 10.1093/cid/ciaa248

Rhen, 2005, Antiinflammatory action of glucocorticoids—new mechanisms for old drugs., N Engl J Med, 353, 1711, 10.1056/NEJMra050541

Steinberg, 2006, Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome., N Engl J Med, 354, 1671, 10.1056/NEJMoa051693

Villar, 2020, Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial., Lancet Respir Med, 8, 267, 10.1016/S2213-2600(19)30417-5

Lee, 2004, Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients., J Clin Virol, 31, 304, 10.1016/j.jcv.2004.07.006

Arabi, 2018, Corticosteroid Therapy for critically ill patients with Middle East respiratory syndrome., Am J Respir Crit Care Med, 197, 757, 10.1164/rccm.201706-1172OC

Ni, 2019, The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis., Crit Care, 23, 99, 10.1186/s13054-019-2395-8

Horby, Dexamethasone in hospitalized patients with Covid-19—preliminary report., N Engl J Med

Tomazini, COVID-19–associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial., Rev Bras Ter Intensiva

Ranieri, 2012, Acute respiratory distress syndrome: the Berlin definition., JAMA, 307, 2526

Harris, 2019, The REDCap consortium: building an international community of software platform partners., J Biomed Inform, 95, 10.1016/j.jbi.2019.103208

Annane, 2017, Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients, I: Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017., Crit Care Med, 45, 2078, 10.1097/CCM.0000000000002737

Béduneau, 2017, Epidemiology of weaning outcome according to a new definition: the WIND Study., Am J Respir Crit Care Med, 195, 772, 10.1164/rccm.201602-0320OC

Cavalcanti, 2017, Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial., JAMA, 318, 1335, 10.1001/jama.2017.14171

Blenkinsop, 2019, Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework., Clin Trials, 16, 132, 10.1177/1740774518823551

Neto, 2016, Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study., Lancet Respir Med, 4, 882, 10.1016/S2213-2600(16)30305-8

Ferrando, Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS., Intensive Care Med

Moreno, 2005, SAPS 3—from evaluation of the patient to evaluation of the intensive care unit, II: development of a prognostic model for hospital mortality at ICU admission., Intensive Care Med, 31, 1345, 10.1007/s00134-005-2763-5

Metnitz, 2005, SAPS 3—from evaluation of the patient to evaluation of the intensive care unit, I: objectives, methods and cohort description., Intensive Care Med, 31, 1336, 10.1007/s00134-005-2762-6

Grasselli, Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy., JAMA Intern Med

Wang, 2020, Clinical course and outcomes of 344 intensive care patients with COVID-19., Am J Respir Crit Care Med, 201, 1430, 10.1164/rccm.202003-0736LE

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study., Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3

Cao, 2016, Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia., Crit Care Med, 44, e318, 10.1097/CCM.0000000000001616

Lehmann, 1975, Nonparametrics: Statistical Methods Based on Ranks

World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19. Posted March 11, 2020. Accessed March 25, 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

World Health Organization. COVID-19 therapeutic trial synopsis. Draft February 18, 2020. Accessed July 28, 2020. https://www.who.int/blueprint/priority-diseases/key-action/COVID-19_Treatment_Trial_Design_Master_Protocol_synopsis_Final_18022020.pdf

Uso de Supporte na Unidade de Principais Desfechos—Internaçõis em UTI Adulto com Desfecho Hospitalar Atribuísdo. UTIs Brasileiras. Updated August 19, 2020. Accessed July 31, 2020. http://www.utisbrasileiras.com.br/sari-covid-19/benchmarking-covid-19/?